FB-1006

N/A

Report date: 2025/05/26 17:36:32
NME

Base Information

Drug NameFB-1006
Drug Alias NameFB-10064B06-01
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNeurons modulators
TargetsUpdating
Therapy Area/IndicationsAmyotrophic Lateral Sclerosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator Companies4b Technologies (Suzhou) Ltd
China Registration ClassN/A

Develop Information

Active Companies4b Technologies (Suzhou) Ltd
Inactive CompaniesN/A
Active IndicationsAmyotrophic Lateral Sclerosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A